European Journal of Endocrinology

Papers
(The H4-Index of European Journal of Endocrinology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy356
MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID-19254
Thyrotoxicosis in patients with COVID-19: the THYRCOV study236
MANAGEMENT OF ENDOCRINE DISEASE: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion113
GLOBAL ENDOCRINOLOGY: Global perspectives in endocrinology: coverage of iodized salt programs and iodine status in 2020109
Management of Endocrine Disease: Osteogenesis imperfecta: an update on clinical features and therapies104
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre93
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency80
European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARA76
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study60
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome56
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors56
Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality56
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism55
Efficacy and safety of larotrectinib in patients with TRK fusion-positive thyroid carcinoma54
GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes53
DIAGNOSIS OF ENDOCRINE DISEASE: Diagnosing and classifying diabetes in diseases of the exocrine pancreas53
DIAGNOSIS OF ENDOCRINE DISEASE: Post-pancreatitis diabetes mellitus: prime time for secondary disease49
MANAGEMENT OF ENDOCRINE DISEASE: Thyroid and female infertility: more questions than answers?!48
ENDOCRINOLOGY IN THE TIME OF COVID-19: Remodelling diabetes services and emerging innovation47
The spectrum of thyroid function tests during hospitalization for SARS COV-2 infection45
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia45
Abiraterone acetate treatment lowers 11-oxygenated androgens42
Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement41
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia39
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study39
Multiple testing: when is many too much?38
Epidemiology of pheochromocytoma and paraganglioma: population-based cohort study38
ESE Clinical Practice Guideline on functioning and nonfunctioning pituitary adenomas in pregnancy38
ENDOCRINOLOGY IN THE TIME OF COVID-19: Diagnosis and management of gestational diabetes mellitus37
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients36
Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?35
MANAGEMENT OF ENDOCRINE DISEASE: Does gender matter in the management of acromegaly?35
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline35
Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls34
Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism34
0.035430192947388